Evotec Future Growth
Future criteria checks 4/6
Evotec is forecast to grow earnings and revenue by 50.1% and 12.9% per annum respectively. EPS is expected to grow by 45.2% per annum. Return on equity is forecast to be 8.2% in 3 years.
Key information
50.1%
Earnings growth rate
45.2%
EPS growth rate
Life Sciences earnings growth | 21.6% |
Revenue growth rate | 12.9% |
Future return on equity | 8.2% |
Analyst coverage | Good |
Last updated | 03 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,182 | 117 | 221 | 278 | 8 |
12/31/2025 | 1,047 | 74 | 112 | 221 | 11 |
12/31/2024 | 880 | 10 | -16 | 144 | 9 |
12/31/2023 | 781 | -84 | -180 | 36 | N/A |
9/30/2023 | 821 | -95 | -192 | -18 | N/A |
6/30/2023 | 798 | -103 | -247 | -43 | N/A |
3/31/2023 | 779 | -117 | -54 | 137 | N/A |
12/31/2022 | 751 | -176 | 24 | 206 | N/A |
9/30/2022 | 698 | -180 | 121 | 297 | N/A |
6/30/2022 | 684 | 2 | 194 | 322 | N/A |
3/31/2022 | 650 | 90 | 58 | 183 | N/A |
12/31/2021 | 618 | 216 | 3 | 122 | N/A |
9/30/2021 | 571 | 247 | -58 | 86 | N/A |
6/30/2021 | 541 | 112 | -50 | 93 | N/A |
3/31/2021 | 515 | 42 | -99 | 20 | N/A |
12/31/2020 | 501 | 6 | -54 | 45 | N/A |
9/30/2020 | 485 | 14 | -4 | 62 | N/A |
6/30/2020 | 470 | 35 | 0 | 46 | N/A |
3/31/2020 | 462 | 42 | 43 | 82 | N/A |
12/31/2019 | 446 | 38 | 10 | 42 | N/A |
9/30/2019 | 419 | 61 | 1 | 29 | N/A |
6/30/2019 | 404 | 77 | 46 | 74 | N/A |
3/31/2019 | 398 | 94 | 109 | 139 | N/A |
12/31/2018 | 375 | 84 | 128 | 156 | N/A |
9/30/2018 | 370 | 63 | 109 | 135 | N/A |
6/30/2018 | 338 | 31 | 54 | 80 | N/A |
3/31/2018 | 294 | 20 | -2 | 19 | N/A |
12/31/2017 | 264 | 23 | -7 | 11 | N/A |
9/30/2017 | 215 | 28 | N/A | 64 | N/A |
6/30/2017 | 193 | 35 | N/A | 73 | N/A |
3/31/2017 | 178 | 36 | N/A | 74 | N/A |
12/31/2016 | 165 | 28 | N/A | 67 | N/A |
9/30/2016 | 160 | 18 | N/A | 5 | N/A |
6/30/2016 | 148 | 6 | N/A | -6 | N/A |
3/31/2016 | 144 | 17 | N/A | -2 | N/A |
12/31/2015 | 128 | 17 | N/A | 16 | N/A |
9/30/2015 | 119 | 12 | N/A | 19 | N/A |
6/30/2015 | 104 | 11 | N/A | 23 | N/A |
3/31/2015 | 93 | -4 | N/A | 9 | N/A |
12/31/2014 | 89 | -7 | N/A | -4 | N/A |
9/30/2014 | 85 | -29 | N/A | 6 | N/A |
6/30/2014 | 89 | -25 | N/A | 2 | N/A |
3/31/2014 | 86 | -27 | N/A | 1 | N/A |
12/31/2013 | 86 | -25 | N/A | 7 | N/A |
9/30/2013 | 83 | -10 | N/A | 8 | N/A |
6/30/2013 | 82 | -4 | N/A | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EVTA is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: EVTA is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: EVTA is expected to become profitable in the next 3 years.
Revenue vs Market: EVTA's revenue (12.9% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: EVTA's revenue (12.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: EVTA's Return on Equity is forecast to be low in 3 years time (8.2%).